Events

MorphoSys AG will publish its first six months’ 2019 results on August 6, 2019 at 10:00pm CEST.

Presentation Made at the 10th International AIDS Society Conference on HIV Science

SGX-listed Singapore eDevelopment Ltd is pleased to announce the results of clinical trials conducted on Laetose, a low-glycemic, naturally modified sugar, developed by its U.S. biomedical subsidiary Global BioLife Inc..

Retrophin, Inc. announced it will report second quarter 2019 financial results on Tuesday, August 6, 2019 after the close of the U.S. financial markets.

In the early 1980s, Genentech produced the first biotech drug – insulin.

JADAK, a business unit of Novanta Corporation will be attending the 71st AACC Annual Scientific Meeting & Clinical Lab Expo at the Anaheim Convention Center August 6-8 in Booth #804.

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, announced that it will host a conference call on Thursday, August 1, 2019 at 5pm ET to discuss second quarter 2019 financial results and provide a corporate update.

InvestAcure, PBC, honored 10 leading bioindustry scientists with the Cure Coin Award for their outstanding work developing groundbreaking scientific discoveries into lifesaving therapeutics for Alzheimer’s, CTE and other related Dementias.

Hospital Management Asia 2019, the annual event for Asian healthcare leaders, will be held September 11-12, 2019, at the National Convention Centre of Vietnam.

Eisai Co., Ltd. announced the presentation and discussion about the treatment, including oral beta amyloid cleaving enzyme (BACE) inhibitor elenbecestat(1) research data on Alzheimer’s disease(AD), were given in the AAIC’s Focused Topic Session “Discussion of BACEi Trial Findings: Challenges and Opportunities” at the Alzheimer’s Association International Conference (AAIC) held in Los Angeles, California, United States, from July 14 to 18, 2019.